Broussonin E could suppress inflammation by modulating macrophages activation state via inhibiting the ERK and p38 MAPK and enhancing JAK2-STAT3 signaling pathway, and can be further developed as a promising drug for the treatment of inflammation-related diseases such as atherosclerosis.
Molekulargewicht:
288.34
Reinheit:
99.86%
CAS Nummer:
[90902-21-9]
Formel:
C17H20O4
Target-Kategorie:
JAK|||STAT|||ERK|||IL Receptor|||COX|||p38 MAPK
TN3541
TN3541
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
